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Dynamic nuclear spin polarization (DNP), in which polari-
zation is transferred from electron to nuclear spins at low 
temperature and high magnetic field, has a long history, 
with the first experiments being performed in the 1950s 
[1]. However, it was not until 2003, when it was shown that 
molecules containing hyperpolarized 13C spins at ~ 1.2 K 
could be rapidly warmed to room temperature, with sub-
stantial retention of this nuclear spin polarization [2], that 
the power of this technology was unleashed for solution 
state NMR studies. A major focus has been on metabolic 
imaging with hyperpolarized 13C-labeled cell substrates, 
where the > 104 gain in sensitivity has enabled 13C magnetic 
resonance spectroscopic (MRSI) imaging of injected hyper-
polarized 13C-labelled substrates (probes) in the body and 
their biochemical conversion to metabolic products. Basic 
and preclinical research leveraging these hyperpolarized 
probes (reviewed in [3–6]), culminated in translation of this 
approach to the clinic with a study of hyperpolarized [1-13C]
pyruvate metabolism in prostate cancer [7]. The technique 
now stands on the threshold of wider clinical application 
with the publication of further studies in prostate cancer 
[8–12], and initial studies of hyperpolarized [1-13C]pyruvate 
metabolism in brain [13, 14] and heart tissue [15, 16] and in 
tumors of the brain [17–20], breast [21, 22], pancreas [23] 
and kidney [24]. An alternative approach to hyperpolarizing 
13C spins, which is reviewed in this issue, is to transfer spin 
order from parahydrogen. The advantage of this method is 
that the equipment is less expensive and polarization times 
are much shorter, allowing for semi-continuous production. 
However, the levels of polarization achieved in molecules 
of immediate interest, such as pyruvate, are much lower and 
although [1-13C]pyruvate polarized using this method has 
been used in vivo the technique is at a much earlier stage on 
the path to clinical translation.
[1-13C]pyruvate has been the most widely used substrate 
as it can be polarized to high levels (> 60% at 7T [25]) with 
sufficiently long 13C  T1 relaxation times in vivo to facilitate 
metabolic imaging. The door is now open to pursue many 
new probes but as the field is consolidating, it faces 2 major 
challenges: (1) What is the role of this imaging modality in 
the management of disease? (2) Can some of the technical 
hurdles facing hyperpolarized MRI be overcome in order to 
facilitate widespread use of this approach.
1. Preclinical and recent clinical studies have suggested 
that hyperpolarized metabolic imaging can provide a 
non-radioactive approach to assess tumor grade, pro-
gression and treatment response [8, 11, 12, 19, 22]. 
Beyond cancer, this has further been exemplified in 
highly metabolic organs including studies in the brain 
and heart, where understanding disease can be unlocked 
by flux measurements using HP MRI. The technique 
has not the breadth of nuclear medicine imaging, but 
then this has a history of more than 50 years in patients. 
In order to progress the field, many more studies are 
required to truly say something relevant about human 
biology, though current technical limitations preclude 
such studies from being achieved.
2. While high polarizations have been achieved for sub-
strates at high concentration, current approaches are 
limited due to low throughput, long polarization times 
and challenges with respect to final concentrations. New 
developments highlighted in this special issue provide 
dramatic improvements in both polarization methodolo-
gies and the ability to separate polarization from dissolu-
tion. These strategies can reduce the technical burdens 
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of hyperpolarization and could facilitate its application 
to clinical studies. Further, many imaging approaches 
have been designed to encode these rapidly decaying 
and interconverting signals. Uniformity across plat-
forms is required to be able to compare such data. In an 
effort to get closer to consensus, reviews from experts in 
hyperpolarized imaging are needed which compare the 
strengths and weaknesses of these imaging strategies.
While these technical hurdles must be overcome to truly 
address the needs of the field, the future is encouraging and 
new developments are paving the way to a more holistic 
view of metabolism in vivo.
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